JPMorgan lifted Procter & Gamble to overweight from neutral, raising its price target to $165 from $157. The bank cited an expected margin improvement and a sales pickup driven by restructuring. Analysts say the move signals a return to historic valuation levels for the consumer‑goods giant in the upcoming quarter.

Management forecasts organic sales to climb 2%‑3% in the second half, after a flat second quarter. U.S. performance lags, but Latin America remains the strongest region, while Europe and China target modest growth. The bank highlights inventory normalization and commercial interventions as key drivers for the upcoming quarter and market.

Investors eye the upgrade as a green light for P&G’s scale, marketing spend, and AI investments to lift margins. Yet execution risk remains, especially in regaining U.S. share. Market watchers should monitor the company’s quarterly guidance and the impact of inventory adjustments on earnings momentum for the next quarter overall.